From Startup To $67 Billion Company | 3 Lessons From Moderna's Vaccine Success
Pre-pandemic, biotech company Moderna had never launched a product. Now the company’s vaccine has propelled its market capitalization to $67 billion. Here are three lessons from Moderna’s success
21 April 2021